Literature DB >> 35818160

Multifocal motor neuropathy after SARS-CoV-2 vaccination: a causal or coincidental association?

Fettah Eren1, Recep Aygul1, Sevde Tenekeci1, Serefnur Ozturk1.   

Abstract

Multifocal motor neuropathy (MMN) is an immune-mediated and acquired demyelinating motor polyneuropathy. Several cases of polyneuropathy associated with severe acquired respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination have been reported. However, MMN has not been reported as a complication of SARS-CoV-2 vaccination. In this study, we report a case of MMN with progressive muscle weakness following the second dose of the Pfizer-BioNTech mRNA vaccine. It was diagnosed by clinical evaluation and electroneuromyography. SARS-CoV-2 vaccination is increasing rapidly all over the world. Some cases of polyneuropathy, especially Guillain-Barré syndrome, have been reported after vaccination. This is the first case report of MMN after SARS-CoV-2 vaccination.

Entities:  

Keywords:  Motor neuropathy; SARS-CoV-2; coronavirus disease 2019; muscle weakness; polyneuropathy; vaccination

Mesh:

Substances:

Year:  2022        PMID: 35818160      PMCID: PMC9280831          DOI: 10.1177/03000605221110709

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.573


  15 in total

1.  Consensus criteria for the diagnosis of multifocal motor neuropathy.

Authors:  Richard K Olney; Richard A Lewis; Timothy D Putnam; Joseph V Campellone
Journal:  Muscle Nerve       Date:  2003-01       Impact factor: 3.217

2.  European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision.

Authors: 
Journal:  J Peripher Nerv Syst       Date:  2010-12       Impact factor: 3.494

3.  Guillain-Barré Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence.

Authors:  Daniel A Salmon; Matthew Z Dudley; Bruce C Carleton
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

Review 4.  Multifocal motor neuropathy: current concepts and controversies.

Authors:  Eduardo Nobile-Orazio; Alberto Cappellari; Alberto Priori
Journal:  Muscle Nerve       Date:  2005-06       Impact factor: 3.217

5.  Recurrences, vaccinations and long-term symptoms in GBS and CIDP.

Authors:  Krista Kuitwaard; Martine E Bos-Eyssen; Patricia H Blomkwist-Markens; Pieter A van Doorn
Journal:  J Peripher Nerv Syst       Date:  2009-12       Impact factor: 3.494

Review 6.  Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options.

Authors:  Sven G Meuth; Christoph Kleinschnitz
Journal:  Eur Neurol       Date:  2010-02-11       Impact factor: 1.710

7.  Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?

Authors:  Alessandro Introna; Francesca Caputo; Carlo Santoro; Tommaso Guerra; Maria Ucci; Domenico Maria Mezzapesa; Maria Trojano
Journal:  Clin Neurol Neurosurg       Date:  2021-08-13       Impact factor: 1.876

8.  The CARE guidelines: consensus-based clinical case reporting guideline development.

Authors:  Joel J Gagnier; Gunver Kienle; Douglas G Altman; David Moher; Harold Sox; David Riley
Journal:  Headache       Date:  2013 Nov-Dec       Impact factor: 5.887

Review 9.  Emerging Infection, Vaccination, and Guillain-Barré Syndrome: A Review.

Authors:  Haruki Koike; Atsuro Chiba; Masahisa Katsuno
Journal:  Neurol Ther       Date:  2021-06-12

10.  Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.

Authors:  Almurtada Razok; Abdullah Shams; Ahmed Almeer; Muhammad Zahid
Journal:  Ann Med Surg (Lond)       Date:  2021-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.